Skip to content

The Effect of sexual life re-framing interventional program on improving sexual function in postmenopausal women

The Effect of sexual life re-framing interventional program on improving sexual function in postmenopausal women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160224026756N8
Enrollment
44
Registered
2025-01-21
Start date
2025-01-24
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual function of postmenopausal women. Other sexual dysfunction, not caused by organic disorder or disease

Interventions

Intervention 1: Intervention group: In this study, participants in the intervention group will participate in an educational program consisting of five 90-minute sessions, held weekly in small groups

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having Iranian nationality for couples Consent to participate in the study Natural menopause At least 12 months have passed since the onset of menopause The age range between 40 and 60 years Having primary and higher education Being married and living stably with a husband At least 1 year has passed since the permanent marriage and the woman is the only wife of her husband Score below 28 on the standard Female Sexual Function Index (FSFI) questionnaire

Exclusion criteria

Exclusion criteria: A history of diagnosed major psychological problems undergoing drug treatments A history of drug and alcohol abuse in both wife and husband Premature ejaculation or impotence in husband according to the self-reports Prior participation in sex education classes A history of surgery in the participants and their husbands, such as prostatectomy, hysterectomy, oophorectomy, mastectomy, and other breast surgeries Unpleasant events during the last 6 months, such as the death of parents, etc. Any chronic diseases affects sexual function in the participants and their husbands (including systemic diseases such as liver, kidney, and lung failure), cardiovascular diseases, malignant diseases, psychological diseases, mood disorders (depression, anxiety), ulcerative colitis, vasculitis, thyroid and adrenal cortex diseases, diabetes, high blood pressure, central nervous system disorders, infectious, and sexually transmitted diseases Using the most common groups of medications that affect sexual function in the participants and their husbands

Design outcomes

Primary

MeasureTime frame
Sexual function of postmenopausal women. Timepoint: At the beginning of the study (before the intervention) and one month after the program ended. Method of measurement: Female Sexual Function Index Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahnaz Noroozi

Esfahan University of Medical Sciences

noroozi@nm.mui.ac.ir+98 31 3792 7570

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026